Amgen, one of the world’s leading independent biopharmaceutical companies, plans to build a $365 million state-of-the-art product assembly and packaging facility on 177 acres in The New Albany International Business Park. The project includes greenfield construction of a 270,000-square-foot plant featuring Amgen’s most advanced digital automation and energy efficiency and waste reduction goals. Amgen will create 400 full-time jobs with an estimated annual payroll of $40 million by December 2027.
The New Albany’s incentive package includes a 15-year, 100% real property tax abatement. The city also agreed to design and construct a new public road extending Ganton Parkway from Beech Road west to the Franklin County-Licking County boundary line. Improvements will be made at the intersection of Ganton Parkway and Beech Road to accommodate traffic projections and upgrades to the water and sewer system. Construction is expected to begin in the fall and be completed by June 2024.
The city’s growing Health & Life Sciences and high-tech manufacturing clusters, room for expansion and ability to fast track development and construction were key factors in Amgen’s decision. Central Ohio’s robust bioscience, technology and engineering workforce, post-secondary educational institutions and clinical research hospitals provide the right ingredients for growth.
New Albany’s “vibrant business environment, access to a growing talent pool, favorable operating costs and central location from a logistics perspective were all important reasons behind our decision to locate here,” said Amgen senior vice president of manufacturing Arleen Paulino.
The Amgen facility in New Albany will be built to exacting environmental standards, consistent with the company’s goal of achieving carbon neutrality by 2027. It will work with AEP, also located in the business park, to meet its goals.
“We are excited to welcome Amgen to New Albany. They are a tremendous fit, from their company values to the quality of their products, and we are glad they saw the benefit of New Albany’s robust infrastructure and speed to market capabilities,” said New Albany Mayor Sloan Spalding.
An early pioneer in biotechnology and a world leader in biologic medicines, Amgen is based in Thousand Oaks, California and employs 24,000 in 100 countries and regions worldwide. Amgen’s announcement reinforces New Albany’s reputation as an innovative community and sound business investment with a high quality of life and low cost of living.
Amgen joins American Regent, formerly Pharmaforce, which planted one of the first stakes in the Health & Life Sciences cluster here in 2013. Citing its central location and the area’s talent pool, Hims & Hers, a direct-to-consumer digital health and wellness company, recently built a new mail-order pharmacy and fulfillment center. The city is also home to Mount Carmel New Albany, a specialty hospital focused on inpatient and outpatient orthopedic, neurologic and musculoskeletal care.